Avanos Capital Stock from 2010 to 2024
| AVNS Stock | USD 19.14 0.02 0.10% |
Capital Stock | First Reported 2010-12-31 | Previous Quarter 450 K | Current Value 400 K | Quarterly Volatility 28 K |
Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43 M, Interest Expense of 16.1 M or Selling General Administrative of 286.2 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.26 or PTB Ratio of 1.45. Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.
Avanos | Capital Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.